期刊论文详细信息
Frontiers in Medicine | |
Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis | |
Zhenmei An1  Sheyu Li2  Qingyang Shi3  Shengzhao Zhang4  Na Su4  Ting Xu4  Ling Wang5  | |
[1] Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;Department of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China;West China School of Pharmacy, Sichuan University, Chengdu, China;West China School of Pharmacy, Sichuan University, Chengdu, China; | |
关键词: febuxostat; allopurinol; hyperuricemia; network meta-analysis; cardiovascular safety; Bayesian framework; | |
DOI : 10.3389/fmed.2021.698437 | |
来源: Frontiers | |